Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BN 52021

Known as: BN-52021 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1996
Highly Cited
1996
The present experiments examined the effects of posttraining intra-dorsal striatal (i.e., caudate-putamen) injections of the… Expand
Highly Cited
1996
Highly Cited
1996
Platelet-activating factor (PAF) is overproduced in ischemic brain. Although postischemic PAF antagonist administration protects… Expand
Highly Cited
1995
Highly Cited
1995
BACKGROUND In recent studies, the hypothesis has been raised that the mechanisms by which aspirin acts as a protective anti… Expand
Highly Cited
1993
Highly Cited
1993
Experiments were performed in pentobarbital-anesthetized rats, to study the mechanism of the acute pulmonary edema induced by… Expand
Highly Cited
1991
Highly Cited
1991
Oxygenated free-radicals appear to play a prominent role in mediating damage associated with gastrointestinal diseases… Expand
Highly Cited
1989
Highly Cited
1989
We have investigated the effects of BN 52021 (a specific PAF antagonist derived from Ginkgo biloba) on PAF-induced human… Expand
Highly Cited
1988
Highly Cited
1988
The effect of the potent inflammatory mediator, platelet activating factor (PAF) was studied on the vascular permeability of… Expand
1988
1988
BN-52021 preserves "in vitro" the actively sensitized guinea-pig heart from the immunological reaction. This ginkgolide reduces… Expand
Highly Cited
1986
Highly Cited
1986
BN 52021 is a chemically defined substance extracted from Ginkgo biloba leaves. Its inhibitory potency was tested on washed human… Expand
Highly Cited
1985
Highly Cited
1985
The effect of BN 52021, a selective antagonist of paf-acether (Braquet GB patent 8, 418, 424 July 19, 1984), was studied in… Expand